TELIX Aktie

 

MELBOURNE, Australia and INDIANAPOLIS, April 02, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the appointment of David Gill as a Non-Executive Director (NED), as part of Board expansion and succession planning. The appointment is effective May 11, 20261. Mr. Gill is expected to be appointed as Chair in due course, succeeding Dr. Mark Nelson who will remain on the Board as a NED....

A leading analyst believes investors are undervaluing Telix shares. But why? The post Up 57% since February, why Telix shares could keep leaping higher in 2026 appeared first on The Motley Fool Australia....

Let's see if they are bullish or bearish on these names. The post Buy, hold, sell: Northern Star, Telix, and Virgin Australia shares appeared first on The Motley Fool Australia....

Louvain-la-Neuve, Belgium– March 20, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of radiopharmaceutical production solutions, today announced it has signed a contract with Telix Pharmaceuticals Limited (Telix; ASX: TLX, NASDAQ: TLX), a precision oncology company, for the initial order of four Cyclone® KIUBE cyclotrons at standard IBA conditions1. The systems will be installed at select RLS Radiopharmacies (RLS) sites in the United States (U.S.)....

Telix looks a compelling growth story, with brokers eyeing more than 150% upside. The post Could Telix shares be a millionaire-maker stock? appeared first on The Motley Fool Australia....

Telix shares are now 11% higher for the year-to-date. The post Why are Telix shares racing 8% higher today? appeared first on The Motley Fool Australia....

These shares are starting the week in the red. But why? The post Why Regis Resources, Strike Energy, Telix, and Virgin Australia shares are falling today appeared first on The Motley Fool Australia....

CANBERA (dpa-AFX) - Telix Pharmaceuticals Limited (TLX, TLX.AX) announced the resubmission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TLX101-Px (Pixclara,......

Market weakness is overshadowing this news. The post Telix shares drop despite promising US FDA update appeared first on The Motley Fool Australia....

Telix Pharmaceuticals has resubmitted its FDA application for TLX101-Px, a new brain cancer imaging candidate. The post Telix Pharmaceuticals resubmits FDA application for brain cancer imaging agent appeared first on The Motley Fool Australia....

MELBOURNE, Australia and INDIANAPOLIS, March 16, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the resubmission of a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX101-Px, (Pixclara®1, Floretyrosine F 18 or 18F-FET), an investigational PET2 imaging agent for the characterization of recurrent or progressive glioma (brain cancer) from treatment related changes in both adult and pediatric patients....

Bell Potter sees potential for this stock to rocket over the next 12 months. The post Why Telix shares could smash the market in 2026 with an 80% return appeared first on The Motley Fool Australia....

It's been a bounce-back day for Australian shares, with yesterday's bloodbath somewhat…...

These shares are having a strong session on Tuesday. Let's find out why. The post Why Life360, St George Mining, Telix, and Westgold shares are charging higher today appeared first on The Motley Fool Australia....

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

MELBOURNE, Australia and INDIANAPOLIS, March 10, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that Part 1 of the ProstACT Global Phase 3 study, the safety and dosimetry lead-in for its therapeutic candidate – TLX591-Tx (lutetium-177 (177Lu) rosopatamab tetraxetan) – has achieved its primary objectives, demonstrating an acceptable safety and tolerability profile with no new safety signals observed....

Let's see what this radiopharmaceuticals company has announced this morning. The post Telix shares jump 14% on big news appeared first on The Motley Fool Australia....

Telix Pharmaceuticals reports positive Phase 3 safety results for its investigational prostate cancer therapy, TLX591-Tx. The post Telix Pharmaceuticals reports positive TLX591-Tx Phase 3 results appeared first on The Motley Fool Australia....

MELBOURNE, Australia and INDIANAPOLIS, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces a research collaboration with University Hospital Essen on the PROMISE-PET registry1, defining the potential prognostic value of PSMA-PET2 imaging through artificial intelligence (AI)....

Telix Pharmaceuticals focuses on radiopharmaceuticals for the diagnosis and treatment of cancer....